FABP5 is also increased in various cancers, including triple negative breast cancer [25, 26], bladder cancer [27], pancreatic cancer [28], oral squamous cell carcinoma [29], and intrahepatic cholangiocarcinoma [30]. This evidence concerns the gene FABP5 and cancer.